Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 7.5 USD -1.45% Market Closed
Market Cap: 512.9m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

P/S
Price to Sales

19.5
Current
0
Median
2.5
Industry
Higher than median
Higher than industry value

Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.

P/S
19.5
=
Market Cap
512.4m USD
/
Revenue
26.3m USD
All Countries
Close

P/S Forward Multiples

Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/S
9.7
2-Years Forward
P/S
2.9
3-Years Forward
P/S
1.3

See Also

Discover More